Growth failure and nutrition considerations in chronic childhood wasting diseases

Nutrition in Clinical Practice

Volumn 30, Issue 2, 2015, Pages 227-238

  Kyle, Ursula G ^a   Shekerdemian, Lara S ^a   Coss Bu, Jorge A ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

chronic diseases; failure to thrive; growth; malnutrition; nutrition therapy; pediatrics

Indexed keywords

ANOREXIA; ARTICLE; BASAL METABOLIC RATE; CACHEXIA; CALORIC INTAKE; CATCH UP GROWTH; CHILD; CHILD NUTRITION; CHILDHOOD DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC LIVER DISEASE; CONGENITAL HEART DISEASE; CYSTIC FIBROSIS; GROWTH DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY BOWEL DISEASE; INTESTINE OBSTRUCTION; LEAN BODY WEIGHT; MALABSORPTION; MUSCULAR DYSTROPHY; PAIN; PROTEIN INTAKE; SHORT BOWEL SYNDROME; VITAMIN SUPPLEMENTATION; VOMITING; WASTING SYNDROME; CHILD NUTRITION DISORDERS; FAILURE TO THRIVE; GROWTH; GROWTH DISORDERS; NUTRITIONAL STATUS;

HUMAN IMMUNODEFICIENCY VIRUS;

CHILD; CHILD NUTRITION DISORDERS; CHRONIC DISEASE; FAILURE TO THRIVE; GROWTH; GROWTH DISORDERS; HUMANS; NUTRITIONAL STATUS;

EID: 84927132701     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533614555234     Document Type: Article

References (128)

1. McDonald CM, Olofin I, Flaxman S, et al.. The effect of multiple anthropometric deficits on child mortality: meta-analysis of individual data in 10 prospective studies from developing countries. Am J Clin Nutr. 2013; 97: 896-901
2. Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A. Cancer cachexia - pathophysiology and management. J Gastroenterol. 2013; 48: 574-594
3. Mak RH, Cheung W. Energy homeostasis and cachexia in chronic kidney disease. Pediatr Nephrol. 2006; 21: 1807-1814
4. Griffiths AM. Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently?. Dig Dis. 2009; 27: 404-411
5. Adair LS, Fall CH, Osmond C, et al. Associations of linear growth and relative weight gain during early life with adult health and human capital in countries of low and middle income: findings from five birth cohort studies. Lancet. 2013; 382: 525-534
6. Hoddinott J, Behrman JR, Maluccio JA, et al. Adult consequences of growth failure in early childhood. Am J Clin Nutr. 2013; 98: 1170-1178
7. Victora CG, Adair L, Fall C, et al. Maternal and child undernutrition: consequences for adult health and human capital. Lancet. 2008; 371: 340-357
8. Martorell R. Physical growth and development of the malnourished child: contributions from 50 years of research at INCAP. Food Nutr Bull. 2010; 31: 68-82
9. van Mourik ID, Beath SV, Brook GA, et al. Long-term nutritional and neurodevelopmental outcome of liver transplantation in infants aged less than 12 months. J Pediatr Gastroenterol Nutr. 2000; 30: 269-275
10. Frisancho AR, Garn SM, Ascoli W. Childhood retardation resulting in reduction of adult body size due to lesser adolescent skeletal delay. Am J Phys Anthropol. 1970; 33: 325-336
11. Mauras N. Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects. Horm Res. 2001; 56: 13-18
12. Ballinger A, El-Haj T, Perrett D, et al. The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology. 2000; 118: 544-553
13. Cheung WW, Paik KH, Mak RH. Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol. 2010; 25: 711-724
14. Bacchetta J, Harambat J, Cochat P, Salusky IB, Wesseling-Perry K. The consequences of chronic kidney disease on bone metabolism and growth in children. Nephrol Dial Transplant. 2012; 27: 3063-3071
15. Wong SC, Smyth A, McNeill E, et al. The growth hormone insulin-like growth factor 1 axis in children and adolescents with inflammatory bowel disease and growth retardation. Clin Endocrinol (Oxf). 2010; 73: 220-228
16. Mahesh S, Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr Nephrol. 2008; 23: 41-48
17. De Benedetti F, Meazza C, Oliveri M, et al. Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology. 2001; 142: 4818-4826
18. Walters TD, Griffiths AM. Mechanisms of growth impairment in pediatric Crohn's disease. Nat Pract Clin Gastroenerol. 2009; 6 (9). 513-523
19. Ballinger AB, Savage MO, Sanderson IR. Delayed puberty associated with inflammatory bowel disease. Pediatr Res. 2003; 53: 205-210
20. Walters TD, Gilman AR, Griffiths AM. Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease. Inflamm Bowel Dis. 2007; 13: 424-430
21. Ballinger A. Fundamental mechanisms of growth failure in inflammatory bowel disease. Horm Res. 2002; 58: 7-10
22. Protein and amino acid requirements in human nutrition. Paper presented at: WHO Technical Report Series; Geneva, Switzerland;..
23. Fjeld CR, Schoeller DA, Brown KH. Body composition of children recovering from severe protein-energy malnutrition at two rates of catch-up growth. Am J Clin Nutr. 1989; 50: 1266-1275
24. Spady DW, Payne PR, Picou D, Waterlow JC. Energy balance during recovery from malnutrition. Am J Clin Nutr. 1976; 29: 1073-1088
25. Cravioto J, Béhar M. Proyecto de un plan nacional para eliminar la desnutrición proteico-calórica como causa importante de defunción en niños de 1 a 4 años de edad. Bol Sanit Guatem. 1964; 35: 62-81
26. Modan-Moses D, Yaroslavsky A, Kochavi B, et al. Linear growth and final height characteristics in adolescent females with anorexia nervosa. PLoS One. 2012; 7: e45504
27. Lai HJ, Shoff SM. Classification of malnutrition in cystic fibrosis: implications for evaluating and benchmarking clinical practice performance. Am J Clin Nutr. 2008; 88: 161-166
28. Culhane S, George C, Pearo B, Spoede E. Malnutrition in cystic fibrosis: a review. Nutr Clin Pract. 2013; 28: 676-683
29. Ozen M, Cokugras H, Ozen N, Camcioglu Y, Akcakaya N.. Relation between serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 levels, clinical status and growth parameters in prepubertal cystic fibrosis patients. Pediatr Int. 2004; 46: 429-435
30. Ciro D, Padoan R, Blau H, et al. Growth retardation and reduced growth hormone secretion in cystic fibrosis: clinical observations from three CF centers. J Cyst Fibros. 2012;:
31. Rosenberg LA, Schluchter MD, Parlow AF, Drumm ML. Mouse as a model of growth retardation in cystic fibrosis. Pediatr Res. 2006; 59: 191-195
32. Azcue M, Rashid M, Griffiths A, Pencharz PB. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut. 1997; 41: 203-208
33. Peterson ML, Jacobs DR, Milla CE. Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics. 2003; 112: 588-592
34. Kalnins D, Wilschanski M. Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies. Drug Des Dev Ther. 2012; 6: 151-161
35. Cheung MS, Bridges NA, Prasad SA, et al. Growth in children with cystic fibrosis-related diabetes. Pediatr Pulmonol. 2009; 44: 1223-1225
36. Hameed S, Morton JR, Field PI, et al. Once daily insulin detemir in cystic fibrosis with insulin deficiency. Arch Dis Child. 2011; 97: 464-467
37. Kyle UG, Spoede ET, Mallory GB, et al. Changes in body composition after lung transplantation in children. J Heart Lung Transplant. 2013; 32: 800-806
38. Seikaly MG, Salhab N, Gipson D, Yiu V, Stablein D. Stature in children with chronic kidney disease: analysis of NAPRTCS database. Pediatr Nephrol. 2006; 21: 793-799
39. Gorman G, Frankenfield D, Fivush B, Neu A. Linear growth in pediatric hemodialysis patients. Pediatr Nephrol. 2008; 23: 123-127
40. Rees L, Jones H. Nutritional management and growth in children with chronic kidney disease. Pediatr Nephrol. 2013; 28: 527-536
41. Furth SL. Growth and nutrition in children with chronic kidney disease. Adv Chronic Kidney Dis. 2005; 12: 366-371
42. Borzych D, Rees L, Ha IS, et al. The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 2010; 78: 1295-1304
43. Mak RH, Ikizler AT, Kovesdy CP, et al. Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2011; 2: 9-25
44. Utaka S, Avesani CM, Draibe SA, et al. Inflammation is associated with increased energy expenditure in patients with chronic kidney disease. Am J Clin Nutr. 2005; 82: 801-805
45. Waller S, Ledermann S, Trompeter R, et al. Catch-up growth with normal parathyroid hormone levels in chronic renal failure. Pediatr Nephrol. 2003; 18: 1236-1241
46. K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis. 2005; 46: 1-122
47. Hurtado-Lopez EF, Larrosa-Haro A, Vasquez-Garibay EM, et al. Liver function test results predict nutritional status evaluated by arm anthropometric indicators. J Pediatr Gastroenterol Nutr. 2007; 45: 451-457
48. Protheroe SM, Kelly DA. Cholestasis and end-stage liver disease. Baillieres Clin Gastroenterol. 1998; 12: 823-841
49. Smart KM, Alex G, Hardikar W. Feeding the child with liver disease: a review and practical clinical guide. J Gastroenterol Hepatol. 2011; 26: 810-815
50. Greer R, Lehnert M, Lewindon P, Cleghorn GJ, Shepherd RW. Body composition and components of energy expenditure in children with end-stage liver disease. J Pediatr Gastroenterol Nutr. 2003; 36: 358-363
51. Young S, Kwarta E, Azzam R, Sentongo T. Nutrition assessment and support in children with end-stage liver disease. Nutr Clin Pract. 2013; 28: 317-329
52. Alonso EM. Growth and developmental considerations in pediatric liver transplantation. Liver Transpl. 2008; 14: 585-591
53. Bucuvalas JC, Cutfield W, Horn JA, et al. Chronic liver disease induced resistance to various effects of GH. J Pediatr. 1990; 117: 397-402
54. Scheenstra R, Gerver WJ, Odink RJ, et al. Growth and final height after liver transplantation during childhood. J Pediatr Gastroenterol Nutr. 2008; 47: 165-171
55. Sarna S, Sipila I, Vihervuori E, Koistinen R, Holmberg C. Growth delay after liver transplantation in childhood: studies of underlying mechanisms. Pediatr Res. 1995; 38: 366-372
56. DeRusso PA, Ye W, Shepherd R, et al. Growth failure and outcomes in infants with biliary atresia: a report from the Biliary Atresia Research Consortium. Hepatology. 2007; 46: 1632-1638
57. Utterson EC, Shepherd RW, Sokol RJ, et al. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr. 2005; 147: 180-185
58. McCullough AJ. Malnutrition in liver disease. Liver Transpl. 2000;: S85 - S96
59. Holt RI, Miell JP, Jones JS, Mieli-Vergani G, Baker AJ. Nasogastric feeding enhances nutritional status in paediatric liver disease but does not alter circulating levels of IGF-I and IGF binding proteins. Clin Endocrinol (Oxf). 2000; 52: 217-224
60. Baker A, Stevenson R, Dhawan A, et al. Guidelines for nutritional care for infants with cholestatic liver disease before liver transplantation. Pediatr Transplant. 2007; 11: 825-834
61. Taylor RM, Dhawan A. Assessing nutritional status in children with chronic liver disease. J Gastroenterol Hepatol. 2005; 20: 1817-1824
62. Vaidyanathan B, Nair SB, Sundaram KR, et al. Malnutrition in children with congenital heart disease (CHD) determinants and short term impact of corrective intervention. Indian Pediatr. 2008; 45: 541-546
63. Okoromah CA, Ekure EN, Lesi FE, et al. Prevalence, profile and predictors of malnutrition in children with congenital heart defects: a case-control observational study. Arch Dis Child. 2011; 96: 354-360
64. Wang Z. High ratio of resting energy expenditure to body mass in childhood and adolescence: a mechanistic model. Am J Hum Biol. 2012; 24: 460-467
65. Farrell AG, Schamberger MS, Olson IL, Leitch CA. Large left-to-right shunts and congestive heart failure increase total energy expenditure in infants with ventricular septal defect. Am J Cardiol. 2001; 87: 1128 A10-1131
66. Butte NF Nutrition in Infancy. Nichols TA, ed. Philadelphia, PA: CV Mosby; 1988: 86-99.
67. Nydegger A, Bines JE. Energy metabolism in infants with congenital heart disease. Nutrition. 2006; 22: 697-704
68. Feldt RH, Strickler GB, Weidman WH. Growth of children with congenital heart disease. Am J Dis Child. 1969; 117: 573-579
69. Varan B, Tokel K, Yilmaz G. Malnutrition and growth failure in cyanotic and acyanotic congenital heart disease with and without pulmonary hypertension. Arch Dis Child. 1999; 81: 49-52
70. Nydegger A, Walsh A, Penny DJ, Henning R, Bines JE. Changes in resting energy expenditure in children with congenital heart disease. Eur J Clin Nutr. 2009; 63: 392-397
71. Vaidyanathan B, Radhakrishnan R, Sarala DA, Sundaram KR, Kumar RK. What determines nutritional recovery in malnourished children after correction of congenital heart defects?. Pediatrics. 2009; 124: e294 - e299
72. Sala A, Pencharz P, Barr RD. Children, cancer, and nutrition - a dynamic triangle in review. Cancer. 2004; 100: 677-687
73. Brinksma A, Huizinga G, Sulkers E, et al. Malnutrition in childhood cancer patients: a review on its prevalence and possible causes. Crit Rev Oncol Hematol. 2012; 83: 249-275
74. Donaldson SS, Wesley MN, DeWys WD, et al. A study of the nutritional status of pediatric cancer patients. Am J Dis Child. 1981; 135: 1107-1112
75. Andrassy RJ, Chwals WJ. Nutritional support of the pediatric oncology patient. Nutrition. 1998; 14: 124-129
76. Duffner PK. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. Neurologist. 2004; 10: 293-310
77. Millot F, Baruchel A, Guilhot J, et al. Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial. J Clin Oncol. 2011; 29: 2827-2832
78. Shima H, Tokuyama M, Tanizawa A, et al. Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia. J Pediatr. 2011; 159: 676-681
79. Bansal D, Shava U, Varma N, Trehan A, Marwaha RK. Imatinib has adverse effect on growth in children with chronic myeloid leukemia. Pediatr Blood Cancer. 2012; 59: 481-484
80. Rohrer TR, Beck JD, Grabenbauer GG, et al. Late endocrine sequelae after radiotherapy of pediatric brain tumors are independent of tumor location. J Endocrinol Invest. 2009; 32: 294-297
81. Felicetti F, Manicone R, Corrias A, et al. Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution. J Cancer Res Clin Oncol. 2011; 137: 1343-1348
82. Moreno L, Vaidya SJ, Pinkerton CR, et al. Long-term follow-up of children with high-risk neuroblastoma: the ENSG5 trial experience. Pediatr Blood Cancer. 2013; 60: 1135-1140
83. Chung SJ, Park SW, Kim MK, et al. Growth after hematopoietic stem cell transplantation in children with acute myeloid leukemia. J Korean Med Sci. 2013; 28: 106-113
84. Chae HW, Park YS, Kim DS, et al. Final height and insulin-like growth factor-1 in children with medulloblastoma treated with growth hormone. Childs Nerv Syst. 2013; 29: 1859-1863
85. Patterson BC, Chen Y, Sklar CA, et al. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study. J Clin Endocrinol Metab. 2014; 99: 2030-2037
86. Rohrer TR, Langer T, Grabenbauer GG, et al. Growth hormone therapy and the risk of tumor recurrence after brain tumor treatment in children. J Pediatr Endocrinol Metab. 2010; 23: 935-942
87. Chiabi A, Lebela J, Kobela M, et al. The frequency and magnitude of growth failure in a group of HIV-infected children in Cameroon. Pan Afr Med J. 2012; 11: 15
88. Franklin SL, Geffner ME. Growth hormone: the expansion of available products and indications. Pediatr Clin North Am. 2011; 58: 1141-1165
89. McKinney RE, Robertson JW. Effect of human immunodeficiency virus infection on the growth of young children. Duke Pediatric AIDS Clinical Trials Unit. J Pediatr. 1993; 123: 579-582
90. Newell ML, Borja MC, Peckham C. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics. 2003; 111: e52 - e60
91. Bailey RC, Kamenga MC, Nsuami MJ, Nieburg P, St Louis ME. Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo. Int J Epidemiol. 1999; 28: 532-540
92. Guarino A, Bruzzese E, De Marco G, Buccigrossi V. Management of gastrointestinal disorders in children with HIV infection. Paediatr Drugs. 2004; 6: 347-362
93. Lindsey JC, Hughes MD, McKinney RE, et al. Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children. J Infect Dis. 2000; 182: 1385-1393
94. Guillen S, Ramos JT, Resino R, Bellon JM, Munoz MA. Impact on weight and height with the use of HAART in HIV-infected children. Pediatr Infect Dis J. 2007; 26: 334-338
95. Jain S, Desai N, Bhangoo A. Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS. Rev Endocr Metab Disord. 2013; 14: 113-118
96. Chantry CJ, Cervia JS, Hughes MD, et al. Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy. HIV Med. 2010; 11: 573-583
97. McKinney RE, Johnson GM, Stanley K, et al. A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. J Pediatr. 1998; 133: 500-508
98. Buchacz K, Cervia JS, Lindsey JC, et al. Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children. Pediatrics. 2001; 108: E72
99. Musoke PM, Mudiope P, Barlow-Mosha LN, et al. Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study. BMC Pediatr. 2010; 10: 56
100. Shamir R, Phillip M, Levine A. Growth retardation in pediatric Crohn's disease: pathogenesis and interventions. Inflamm Bowel Dis. 2007; 13: 620-628
101. Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol. 2009; 15: 2570-2578
102. Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012; 46: 581-589
103. Sawczenko A, Ballinger AB, Savage MO, Sanderson IR. Clinical features affecting final adult height in patients with pediatric-onset Crohn's disease. Pediatrics. 2006; 118: 124-129
104. Kappelman MD, Bousvaros A. Nutritional concerns in pediatric inflammatory bowel disease patients. Mol Nutr Food Res. 2008; 52: 867-874
105. Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet. 2011; 24: 313-326
106. De Benedetti F, Alonzi T, Moretta A, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I: a model for stunted growth in children with chronic inflammation. J Clin Invest. 1997; 99: 643-650
107. Bannerjee K, Camacho-Hubner C, Babinska K, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr. 2004; 38: 270-275
108. Walters TD, Griffiths AM. Mechanisms of growth impairment in pediatric Crohn's disease. Nat Rev Gastroenterol Hepatol. 2009; 6: 513-523
109. Soden JS. Clinical assessment of the child with intestinal failure. Semin Pediatr Surg. 2010; 19: 10-19
110. Quiros-Tejeira RE, Ament ME, Reyen L, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr. 2004; 145: 157-163
111. Ricour C, Duhamel JF, Arnaud-Battandier F, et al. Enteral and parenteral nutrition in the short bowel syndrome in children. World J Surg. 1985; 9: 310-315
112. Goulet O, Baglin-Gobet S, Talbotec C, et al. Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg. 2005; 15: 95-101
113. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW. A new treatment for patients with short-bowel syndrome: growth hormone, glutamine, and a modified diet. Ann Surg. 1995; 222: 243-255
114. Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology. 2006; 130: S16 - S28
115. Goulet O. Short bowel syndrome in pediatric patients. Nutrition. 1998; 14: 784-787
116. Nightingale J, Woodward JM, Small B. Guidelines for management of patients with a short bowel. Gut. 2006; 55: iv1 - iv12
117. Yang CF, Duro D, Zurakowski D, et al. High prevalence of multiple micronutrient deficiencies in children with intestinal failure: a longitudinal study. J Pediatr. 2011; 159: 39-44.e1
118. Ovesen L, Chu R, Howard L. The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome. Am J Clin Nutr. 1983; 38: 270-277
119. Davidson ZE, Truby H. A review of nutrition in Duchenne muscular dystrophy. J Hum Nutr Diet. 2009; 22: 383-393
120. Bianchi ML, Biggar D, Bushby K, et al. Endocrine aspects of Duchenne muscular dystrophy. Neuromuscul Disord. 2011; 21: 298-303
121. Angelini C, Peterle E. Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy. Acta Myol. 2012; 31: 9-15
122. Griffiths RD, Edwards RH. A new chart for weight control in Duchenne muscular dystrophy. Arch Dis Child. 1988; 63: 1256-1258
123. Hankard R, Gottrand F, Turck D, et al. Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy. Pediatr Res. 1996; 40: 29-33
124. Hogan SE. Body composition and resting energy expenditure of individuals with Duchenne and Becker muscular dystrophy. Can J Diet Pract Res. 2008; 69: 208-212
125. Zanardi MC, Tagliabue A, Orcesi S, et al. Body composition and energy expenditure in Duchenne muscular dystrophy. Eur J Clin Nutr. 2003; 57: 273-278
126. Elliott SA, Davidson ZE, Davies PS, Truby H. Predicting resting energy expenditure in boys with Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2012; 16: 631-635
127. Cook DM, Rose SR. A review of guidelines for use of growth hormone in pediatric and transition patients. Pituitary. 2012; 15: 301-310
128. Wilson TA, Rose SR, Cohen P, et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr. 2003; 143: 415-421